Market Summery
Market
Research Future (MRFR) predicts the Global Contrast Media Market
Share is projected to grow USD 4.2 billion at a CAGR 4.01% during
the forecast period of 2023 – 2030. Contrast Media is a substance that enhances
the visibility of internal organs during radiography. Medical imaging
plays a crucial role in diagnosis of diseases, like GI disorders, cancer
diagnosis, and cardiovascular complications.
The World Health Organization (WHO) reported that by 2020,
three-quarters of global deaths will be caused due to chronic diseases of which
71-75% of deaths will be due to cardiac related problems. Early detection of
such ailments can help provide patients with better treatment. The
increase in prevalence of chronic disease and cancer patients necessitates
better diagnostic techniques provoking elevated use of contrast media. This is
expected to bolster the contrast media market in the forecast period.
Medical
imaging techniques like, computed tomography (CT) and magnetic resonance
imaging (MRI), extensively use contrast media for deriving images of internal
organs of a body. The increase in the number of both public and private
diagnostic centres availing such sophisticated medical imaging techniques is
another factor identified to propel the market expansion. Owing to technical
advancements, the burgeoning healthcare industry is expected to largely
influence the contrast media market.
For
example, in 2017, GE Healthcare received its FDA approval for Visipaque™
(iodixanol) Injection, a imaging agent that can be used in coronary CT
angiography. Ascelia Pharma, in 2018 announced that it will develop
manganese-based contrast media products, which would likely be a safer
alternative to gadolinium-based contrast media agents. Designing syringeless
contrast media injectors to improve the route of administration of
contrast media, for better patient compliance. Such medical advancements are providing
a platform for launching innovative products. MRFR forecast that launch of new
products can have a positive impact on the global contrast media market growth
in the near future.
Key players
Global
contrast media market players are as below
AMAG
Pharmaceuticals (US)
Bracco
Diagnostic Inc. (Italy)
Lantheus
Medical Imaging (U.S.)
Covidien
(Ireland)
Mallinckrodt
Pharmaceuticals (UK)
Targeson
(US)
nanoPET
Pharma GmbH (Germany)
NanoScan
Imaging (US)
Medrad
Inc. (US)
Guerbet
Group (France)
Subhra
Pharma Private Limited (India)
GE
Healthcare (US)
CMC
Contrast AB (Sweden)
Daiichi
(Japan)
Bayer
Healthcare Pharmaceuticals (Germany)
Segmental Analysis
The
segmental study of the Global Contrast Media Market
Outlook gives a compendious market overview that highlights key
points of the market that benefits our clients to identify growth opportunities
of the market. The contrast media market study is segmented into type,
procedure, application, and route of application.
Based
on the type, the market is segmented into intravenous contrast materials,
iodine-based contrast media agents, and others.
Based
on the application, the market is segmented into nephrological disorders,
oncology, cardiovascular disorders, and others.
Based
on the route of administration, the market is segmented into injectable,
rectal, and oral.
Regional Insights
MRFR’s
regional analysis of the Contrast Media Market insight gives a holistic
approach towards the demographic progress of the market in the forecast years.
Based on the region, the contrast media market is segmented into Asia Pacific,
North America, Europe, and the Rest-of-the-World (RoW).
North
America is expected to dominate the market, holding a significant market share
owing to its strong technological infrastructure. Increase in medical tourism,
rise in the number of cancer patients and patients suffering from chronic
disorders, and market players likely to deliver cost-competitive contrast media
products are factors which are predicted to fuel the regional market
growth.
Robust
economic improvement, existence of influential market players, and
technological advancements in the European region can augment the regional
market proliferation.
The
contrast media market in the Asia Pacific region, led by the rapidly
proliferating healthcare sector and developing economy, has emerged as a
promising market, globally. Increasing markets in countries, such as Japan,
China, and India, are pushing up the growth in the regional market. Moreover,
the APAC Contrast Media Market is driven by the rising population and the
spreading awareness towards the functionalities of contrast media.
The
rapidly growing healthcare industry and emerging economies like India, Japan,
and China in the Asia Pacific region, a huge population, and increase in
awareness towards benefits of contrast media are market dynamics expected to
drive the regional market growth.
Related reports
https://healthcaresubmission.blogspot.com/2023/09/pharmaceutical-sterility-testing-market.html
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
United
States of America
